The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%
Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis and treatment purposes.
Roots Analysis has announced the addition of “CD-47 Therapeutics Market, 2021-2035” report to its list of offerings.
In recent years, the focus of the...
0 Comments
0 Shares